1. Multiple functions of HuR in urinary tumors
   Fa Zhang et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
2. Cytotoxics and Anti-Angiogenics: Metronomic Therapies
   Andreas Pircher et al, 2017, Tumor Angiogenesis CrossRef
3. Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects
   Mei-Lin Chen et al, 2020, Journal of Materials Chemistry B CrossRef
4. Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer
   Jörgen Elgqvist, 2017, International Journal of Molecular Sciences CrossRef
5. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells
   Hui Liu et al, 2018, DNA and Cell Biology CrossRef
6. Cytotoxics and Anti-angiogenics: Metronomic Therapies
   Andreas Pircher et al, 2019, Tumor Angiogenesis CrossRef
7. Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose‐reduced 3‐weekly docetaxel for metastatic castration‐resistant prostate cancer
   Anis A. Hamid et al, 2018, Asia-Pacific Journal of Clinical Oncology CrossRef
8. Sambucus nigra agglutinin as a supporter of docetaxel treatment in metastatic prostate cancer
   Fadime Mutlu İçduygu et al, 2023, Human Gene CrossRef